The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer

by Wang L, Shi T, Feng L, Fan Z, Xu X, Zhou X, Zhang X, Han J, Jing L, Liu J, Shan Y, Liu F, Zuo J, Wang Y
Published 2021-03-01

The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations

by Li H, Wang W, Yang X, Lian J, Zhang S, Cao J, Zhang X, Song X, Jia S, Xue R
Published 2020-07-01

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma

by Li C, Guo J, Zhao L, Hu F, Nie W, Wang H, Zheng X, Shen Y, Gu P, Zhang Y, Zhang X
Published 2019-04-01

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma

by Zhang X, Zheng P, Li Z, Gao S, Liu G
Published 2020-08-01

Follicular Lymphoma Presenting With Monoclonal IgM And MYD88 Mutation: A Case Report And Review Of The Literature

by Xu L, Ding X, Ying L, Zhang X, Lu N
Published 2019-09-01

A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation

by Zhou S, Tang W, Wang Q, Zhang X, Jin X, Xu X, Fu J
Published 2021-02-01

TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma

by Zhang X, Fu Z, Zhang X
Published 2021-08-01

Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy

by Wang H, Zhang L, Si X, Zhang X, Wang M
Published 2018-10-01

Heterogeneity of clinical features and mutation analysis of NTRK1 in Han Chinese patients with congenital insensitivity to pain with anhidrosis

by Li N, Guo S, Wang Q, Duan G, Sun J, Liu Y, Zhang J, Wang C, Zhu C, Liu J, Zhang X
Published 2019-01-01

TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer

by Yu R, Sun T, Zhang X, Li Z, Xu Y, Liu K, Shi Y, Wu X, Shao Y, Kong L
Published 2021-10-01

Transmitted and Acquired HIV-1 Drug Resistance from a Family: A Case Study

by Yan L, Yu F, Zhang H, Zhao H, Wang L, Liang Z, Zhang X, Wu L, Liang H, Yang S, Tang Y, Zhang F
Published 2020-10-01

A New Compound Heterozygous Mutation Of BSCL2 In A Chinese Zhuang Ethnic Family With Congenital Generalized Lipodystrophy

by Qin Y, Zhang X, Xiang L, Shan Q, Li S, Yan J, Lin F
Published 2019-12-01

Expression Level of Wnt5a Was Related to the Therapeutic Effects of First-Generation EGFR-TKIs

by Zhang H, Yang X, Hu F, Li C, Xu J, Nie W, Shen Y, Lou Y, Han B, Zhong H, Zhang X
Published 2020-06-01

Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion

by Zhang X, Feng J, Su X, Lei Y, Wu W, Cheng X
Published 2020-12-01

HNRNPCL1, PRAMEF1, CFAP74, and DFFB: Common Potential Biomarkers for Sporadic and Suspected Lynch Syndrome Endometrial Cancer

by Gao Y, Zhang X, Wang T, Zhang Y, Wang Q, Hu Y
Published 2020-11-01

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study

by Li Q, Jin W, Jin Y, Zheng Z, Zhou X, Wang Q, Ye D, Sun Y, Zhang X, Wang O, Chen E, Cai Y
Published 2018-05-01

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

by Xu J, Liu X, Yang S, Zhang X, Shi Y
Published 2017-10-01

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

by Hou H, Qin K, Liang Y, Zhang C, Liu D, Jiang H, Liu K, Zhu J, Lv H, Li T, Zhang X
Published 2019-06-01